Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical highlights from the National Cancer Data Base, 2000.

A K Stewart1, K I Bland, L S McGinnis

  • 1Commission on Cancer, American College of Surgeons, Chicago, IL, USA.

CA: a Cancer Journal for Clinicians
|July 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma Exchange for Acute Renal Failure of Myeloma-Logical, Yet Ineffective: Plasma Exchange When Myeloma Presents as Acute Renal Failure. A Randomized, Controlled Trial. Ann Int Medicine 143: 777-784, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Metagenomic shotgun sequencing of blood to identify bacteria and viruses in leukemic febrile neutropenia.

PloS one·2022
Same author

The Stickland Reaction Precursor <i>trans</i>-4-Hydroxy-l-Proline Differentially Impacts the Metabolism of Clostridioides difficile and Commensal <i>Clostridia</i>.

mSphere·2022
Same author

Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study.

Digestive diseases and sciences·2022
Same author

High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.

Blood cancer journal·2017
Same author

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial.

Leukemia·2017

The National Cancer Data Base (NCDB) collects extensive cancer data from US hospitals. Analysis of this data informs cancer care practices and outcomes for various malignancies.

Area of Science:

  • Oncology
  • Health Services Research

Background:

  • The National Cancer Data Base (NCDB) is a key resource for cancer research.
  • It collects demographic, diagnostic, treatment, and outcomes data from US hospital cancer registries.
  • Supported by the American Cancer Society and the American College of Surgeons Commission on Cancer.

Purpose of the Study:

  • To highlight principal findings from studies using NCDB data.
  • To showcase the utility of NCDB data for evaluating cancer care practices and outcomes.
  • To demonstrate the NCDB's capacity for analyzing both common and rare cancers.

Main Methods:

  • Analysis of articles published in 1999 and early 2000 that utilized NCDB data.
  • Inclusion of studies based on cancer cases diagnosed between 1985 and 1996.

Related Experiment Videos

  • Leveraging a dataset comprising over 6.4 million cancer cases.

    • Main Results:

    • NCDB data supports analyses across a wide spectrum of cancers, including breast, lung, prostate, and rare malignancies.
    • Findings from diverse studies using NCDB data were published, informing clinical evaluation.
    • The database enables clinical evaluations not feasible with other data sources due to sufficient rare cancer case numbers.

    Conclusions:

    • The NCDB is a valuable empirical resource for understanding cancer patient demographics, treatments, and outcomes.
    • NCDB data facilitates the evaluation of local patient care practices and outcomes at participating hospitals.
    • The comprehensive nature of the NCDB supports robust clinical evaluations, including for rare cancers.